The global Clinical Microbiology Market is witnessing steady growth, driven by factors such as the rise in infectious diseases, government subsidization of healthcare, and increasing research funding.

As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...

Combining a host biomarker with large language model analysis improves lower respiratory tract infection diagnosis in ICU ...

Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of ...

Metagenomic sequencing (mNGS) is a powerful diagnostic tool to detect causative pathogens in clinical microbiological testing. Rapid and accurate classification of metagenomic sequences is a critical ...

Microbial testing laboratories often face challenges such as genetic drift, variability in results, and the need for extensive preparation. These issues can lead to inconsistent results and increased ...

In a recent study posted to Research Square*, researchers evaluated the distribution of microbes on surfaces within a microbiology laboratory. Study: Characterization of SARS-CoV-2 distribution and ...

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...

BioMerieux is a niche player in the fragmented in vitro diagnostic market and has specialty positioning in clinical and industrial microbiology and multiplex molecular diagnostics, or syndromic ...

The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.